Börje Ljungberg

Vetenskaplig meritering: Docent

Kontakt

borje.ljungberg@umu.se

090-786 72 84

Verksam som

Professor vid Institutionen för diagnostik och intervention

5A, Målpunkt H62, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Real-world drivers of treatment choices in synchronous metastatic renal cell carcinoma

BJUI Compass, John Wiley & Sons 2026, Vol. 7, (1)

Almdalal, Tarik; Fahlén, Maja; Harmenberg, Ulrika; et al.

Spectral and stiffness characterization of whole prostate gland to assist superficial cancer detection during radical prostatectomy

Spectrochimica Acta Part A - Molecular and Biomolecular Spectroscopy, Elsevier 2026, Vol. 347

Lindahl, Olof A; Gorzsás, András; Bergh, Anders; et al.

Urine glycosaminoglycan scores for surveillance of recurrence in intermediate- and high-risk nonmetastatic clear cell renal cell carcinoma: an observational prospective multicentre diagnostic test cohort study

European Urology Oncology, Elsevier 2025, Vol. 8, (6) : 1566-1574

Dabestani, Saeed; Azawi, Nessn H.; Campi, Riccardo; et al.

Diagnosis and initial management of renal cell carcinoma

Primer on urology, Cham: Springer 2025 : 273-288

Dabestani, Saeed; Ljungberg, Börje

Non-surgical management vs active treatment in T1a renal cell carcinoma: a population-based study

BJU International

Hashim, Bassam Mazin; Rosenblad, Andreas Karlsson; Lundgren, Per-Olof; et al.

Addressing the need for predictive tools in postoperative abdominal wall complications after nephrectomy: evaluation of a novel abdominal bulge grading system using computed tomography

Acta Radiologica Open, Sage Publications 2025, Vol. 14, (8)

Inkiläinen, Aapo; Ljungberg, Börje; Blomqvist, Lennart; et al.

Healthcare costs in relation to increased use of preoperative renal tumour biopsies

Scandinavian journal of urology, MJS Publishing 2025, Vol. 60 : 66-72

Lind, Agnes; Mazin Hashim, Bassam; Hagman, Matilda; et al.

Liquid biomarkers associate with TGF-β Type I receptor and hypoxia in kidney cancer

Signal Transduction and Targeted Therapy, Springer Nature 2025, Vol. 10, (1)

Mallikarjuna, Pramod; Erdem, Cemal; Ilundain Beorlegui, Ruben; et al.

Hospital volume as a determinant of outcomes after partial nephrectomy: a systematic review by the european association of urology renal cell carcinoma guidelines panel

European Urology Oncology, Elsevier 2025, Vol. 8, (3) : 616-622

Marconi, Lorenzo; Kuusk, Teele; Hora, Milan; et al.

Reply to the letter to the editor about “recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis” by Lundgren and Radros

World journal of urology, Springer Nature 2025, Vol. 43, (1)

Rosenblad, Andreas Karlsson; Hashim, Bassam Mazin; Lindblad, Per; et al.

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

BMC Cancer, BioMed Central (BMC) 2024, Vol. 24, (1)

Iisager, Laura; Ahrenfeldt, Johanne; Donskov, Frede; et al.

Reply to Letter to the Editor about "Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis" by Qiang et al

World journal of urology, Springer Nature 2024, Vol. 42, (1)

Karlsson Rosenblad, Andreas; Hashim, Bassam Mazin; Lindblad, Per; et al.

Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma

Scandinavian journal of urology, Medical Journals Sweden 2024, Vol. 59 : 26-30

Kröger Dahlin, Britt-Inger; Hlodan, Jan; Ghaffarpour, Ramin; et al.

Is Partial Nephrectomy A Primary Option for Patients with T1b Renal Cell Carcinoma—A National Population-Based Study

Urology Research and Practice, Aves Yayincilik A.Ş. 2024, Vol. 50, (6) : 322-327

Lundstam, Sven; Almdalal, Tarik; Karlsson Rosenblad, Andreas; et al.

Diagnostic accuracy and safety of renal tumour biopsy in patients with small renal masses and its impact on treatment decisions

Scandinavian journal of urology, Medical Journals Sweden 2024, Vol. 59 : 141-146

Mazin Hashima, Bassam; Chabok, Abbas; Ljungberg, Börje; et al.

Recurrences after nephron-sparing treatments of renal cell carcinoma: a competing risk analysis

World journal of urology, Springer Nature 2024, Vol. 42, (1)

Rosenblad, Andreas Karlsson; Hashim, Bassam Mazin; Lindblad, Per; et al.

Expression of HIF‑α and their association with clinicopathological parameters in clinical renal cell carcinoma

Upsala Journal of Medical Sciences, Uppsala Medical Society 2024, Vol. 129

Tumkur Sitaram, Raviprakash; Ljungberg, Börje

End-stage renal disease after renal cancer surgery: risk factors and overall survival

Scandinavian journal of urology, Medical Journals Sweden 2024, Vol. 59 : 109-116

Åkerlund, John; Ljungberg, Börje; Lundstam, Sven; et al.

Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma: results from the National Swedish Kidney Cancer Register

Scandinavian journal of urology, Taylor & Francis Group 2023, Vol. 57, (1-6) : 67-74

Almdalal, Tarik; Karlsson Rosenblad, Andreas; Hellström, Mikael; et al.

The 2022 updated European association of urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma

European Urology, Elsevier 2023, Vol. 83, (1) : 10-14

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.

Dietary vitamin D intake and the bladder cancer risk: a pooled analysis of prospective cohort studies

Clinical Nutrition, Elsevier 2023, Vol. 42, (8) : 1462-1474

Boot, Iris W.A.; Wesselius, Anke; Yu, Evan Y.W.; et al.

Reply to Yaxiong Tang, Xu Hu, Kan Wu, Yanxiang Shao, and Xiang Li’s Letter to the Editor re: Umberto Capitanio, Jens Bedke, Laurence Albiges, et al. A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel. Eur Urol. 2022;83:3–5

European Urology, Elsevier 2023, Vol. 83, (3) : e74-e75

Capitanio, Umberto; Bedke, Jens; Albiges, Laurence; et al.

A renewal of the tnm staging system for patients with renal cancer to comply with current decision-making: Proposal from the European Association of Urology guidelines panel

European Urology, Elsevier 2023, Vol. 83, (1) : 3-5

Capitanio, Umberto; Bedke, Jens; Albiges, Laurence; et al.

Reproductive and hormonal factors and risk of renal cell carcinoma among women in the european prospective investigation into cancer and nutrition

Cancer Medicine, John Wiley & Sons 2023, Vol. 12, (14) : 15588-15600

Clasen, Joanna L.; Mabunda, Rita; Heath, Alicia K.; et al.

Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma

The journal of pathology. Clinical research, John Wiley & Sons 2023, Vol. 9, (4) : 261-272

de Alwis, Roger; Schoch, Sarah; Islam, Mazharul; et al.

European association of urology guidelines panel on renal cell carcinoma update on the new world health organization classification of kidney tumours 2022: the urologist's point of view

European Urology, Elsevier 2023, Vol. 83, (2) : 97-100

Hora, Milan; Albiges, Laurence; Bedke, Jens; et al.

Local treatment of recurrent renal cell carcinoma may have a significant survival effect across all risk-of-recurrence groups

European Urology Open Science, Elsevier 2023, Vol. 47 : 65-72

Marconi, Lorenzo; Kuusk, Teele; Capitanio, Umberto; et al.

Predictors for complication in renal cancer surgery: a national register study

Scandinavian journal of urology, Medical Journals Sweden 2023, Vol. 58 : 38-45

Åkerlund, John; Sundqvist, Pernilla; Ljungberg, Börje; et al.

The relationship between blood pressure and risk of renal cell carcinoma

International Journal of Epidemiology, Oxford University Press 2022, Vol. 51, (4) : 1317-1327

Alcala, Karine; Mariosa, Daniela; Smith-Byrne, Karl; et al.

Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease: A National Register Study

European Urology Open Science, Vol. 39 : 22-28

Almadalal, Tarik; Sundqvist, Pernilla; Harmenberg, Ulrika; et al.

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

European Urology, Elsevier 2022, Vol. 81, (2) : 134-137

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry

European Urology Open Science, Elsevier 2022, Vol. 45 : 12-22

Bjartell, Anders; Costa, Luis; Kramer, Gero; et al.

Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort

Nutrients, MDPI 2022, Vol. 14, (17)

Claeys, Liesel; De Saeger, Sarah; Scelo, Ghislaine; et al.

Recurrence pattern in localized RCC: results from a European multicenter database (RECUR)

Urologic Oncology, Elsevier 2022, Vol. 40, (11) : 494.e11-494.e17

Fallara, Giuseppe; Larcher, Alessandro; Dabestani, Saeed; et al.

Mild-to-moderate kidney dysfunction and cardiovascular disease: Observational and mendelian randomization analyses

Circulation, Wolters Kluwer 2022, Vol. 146, (20) : 1507-1517

Gaziano, Liam; Sun, Luanluan; Arnold, Matthew; et al.

Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years

PLOS ONE, Public Library of Science 2022, Vol. 17, (1)

Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.

Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic

European Journal of Cancer Prevention, Lippincott Williams & Wilkins 2022, Vol. 31, (3) : 228-234

Hemminki, Kari; Försti, Asta; Hemminki, Akseli; et al.

Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma

Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (5-6) : 383-390

Karlsson Rosenblad, Andreas; Sundqvist, Pernilla; Harmenberg, Ulrika; et al.

Ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in metastatic renal cell carcinoma: a randomized phase 2 study

European Urology Open Science, Elsevier 2022, Vol. 40 : 38-45

Lindskog, Magnus; Laurell, Anna; Kjellman, Anders; et al.

Kidney tumor biopsy – an unmet need for personalized treatment

Scandinavian journal of urology, Taylor & Francis 2022, Vol. 56, (5-6) : 373-374

Ljungberg, Börje

European Association of Urology Guidelines on Renal Cell Carcinoma: the 2022 Update

European Urology, Elsevier 2022, Vol. 82, (4) : 399-410

Ljungberg, Börje; Albiges, Laurence; Abu-Ghanem, Yasmin; et al.

Reply to Yongbao Wei, Ruochen Zhang, and Le Lin's Letter to the Editor re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82:e88

European Urology, Elsevier 2022, Vol. 82, (4) : e111-e112

Ljungberg, Börje; Bedke, Jens; Capitanio, Umberto; et al.

Inflammatory response markers and survival prediction in patients with renal cell carcinoma

Scandinavian journal of urology, Taylor & Francis Group 2022, Vol. 56, (1) : 47-52

Mountzias, Alexander; Hultdin, Johan; Hlodan, Jan; et al.

Spinal anaesthesia with clonidine: pain relief and earlier mobilisation after open nephrectomy – a randomised clinical trial

Journal of international medical research, Sage Publications 2022, Vol. 50, (9) : 1-12

Thurm, Mascha; Hultin, Magnus; Johansson, Göran; et al.

Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?

BJU International, John Wiley & Sons 2021, Vol. 128, (3) : 386-394

Abu-Ghanem, Yasmin; Powles, Thomas; Capitanio, Umberto; et al.

The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery: Results from RECUR Consortium

European Urology Oncology, Elsevier 2021, Vol. 4, (3) : 473-482

Abu-Ghanem, Yasmin; Powles, Thomas; Capitanio, Umberto; et al.

The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care

European Urology, Elsevier 2021, Vol. 80, (4) : 393-397

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma

European Urology, Elsevier 2021, Vol. 79, (3) : 339-342

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; et al.

Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis: What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature

European Urology Oncology, Elsevier 2021, Vol. 4, (1) : 22-41

Campi, Riccardo; Stewart, Grant D.; Staehler, Michael; et al.

The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium

PLoS Medicine, Public Library of Science (PLOS) 2021, Vol. 18, (9)

Guida, Florence; Tan, Vanessa Y.; Corbin, Laura J.; et al.

Visa publikationer i DiVA

Forskningsprojekt

1 januari 2022

Bulging efter nefrektomi

1 januari 2018

Börje Ljungberg projekt